Dr. John Vetto, MD

NPI: 1629086103
Total Payments
$37,355
2022 Payments
$178.60
Companies
7
Transactions
43
Medicare Patients
1,737
Medicare Billing
$197,147

Payment Breakdown by Category

Consulting$20,720 (55.5%)
Other$10,656 (28.5%)
Travel$3,913 (10.5%)
Food & Beverage$2,066 (5.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $20,720 4 55.5%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $10,600 7 28.4%
Travel and Lodging $3,913 15 10.5%
Food and Beverage $2,066 16 5.5%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $56.00 1 0.1%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $12,468 15 $0 (2020)
Amgen Inc. $11,309 16 $0 (2018)
Cardinal Health 414, LLC $11,131 4 $0 (2018)
NOVADAQ TECHNOLOGIES INC. $2,055 3 $0 (2017)
Genentech USA, Inc. $213.30 3 $0 (2018)
E.R. Squibb & Sons, L.L.C. $108.88 1 $0 (2022)
Regeneron Healthcare Solutions, Inc. $69.72 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2022 $178.60 2 E.R. Squibb & Sons, L.L.C. ($108.88)
2020 $2,840 1 Novartis Pharmaceuticals Corporation ($2,840)
2018 $18,926 17 Cardinal Health 414, LLC ($11,131)
2017 $15,411 23 Amgen Inc. ($8,621)

All Payment Transactions

43 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
05/25/2022 Regeneron Healthcare Solutions, Inc. LIBTAYO (Biological) Food and Beverage In-kind items and services $69.72 General
Category: ONCOLOGY
03/09/2022 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $108.88 General
Category: Oncology
06/13/2020 Novartis Pharmaceuticals Corporation MEKINIST (Drug), TAFINLAR Consulting Fee Cash or cash equivalent $2,840.00 General
Category: ONCOLOGY
12/17/2018 Cardinal Health 414, LLC Lymphoseek (Drug) Consulting Fee Cash or cash equivalent $9,900.00 General
Category: Hematology Oncology
12/17/2018 Cardinal Health 414, LLC Lymphoseek (Drug) Travel and Lodging Cash or cash equivalent $501.06 General
Category: Hematology Oncology
10/26/2018 Cardinal Health 414, LLC Lymphoseek (Drug) Food and Beverage In-kind items and services $458.84 General
Category: Hematology Oncology
10/26/2018 Cardinal Health 414, LLC Lymphoseek (Drug) Travel and Lodging In-kind items and services $271.00 General
Category: Hematology Oncology
10/23/2018 Genentech USA, Inc. Food and Beverage In-kind items and services $36.93 General
05/25/2018 Amgen Inc. IMLYGIC (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $200.00 General
Category: Oncology
04/05/2018 Amgen Inc. IMLYGIC (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,400.00 General
Category: Oncology
04/03/2018 Amgen Inc. IMLYGIC (Biological) Food and Beverage In-kind items and services $88.35 General
Category: Oncology
02/24/2018 Novartis Pharmaceuticals Corporation MEKINIST (Drug), TAFINLAR Consulting Fee Cash or cash equivalent $3,992.00 General
Category: ONCOLOGY
02/24/2018 Novartis Pharmaceuticals Corporation TAFINLAR (Drug), MEKINIST Travel and Lodging In-kind items and services $366.00 General
Category: ONCOLOGY
02/24/2018 Novartis Pharmaceuticals Corporation MEKINIST (Drug), TAFINLAR Travel and Lodging In-kind items and services $253.49 General
Category: ONCOLOGY
02/24/2018 Novartis Pharmaceuticals Corporation SEG101 (Biological) Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program Cash or cash equivalent $56.00 General
02/24/2018 Novartis Pharmaceuticals Corporation MEKINIST (Drug), TAFINLAR Food and Beverage In-kind items and services $54.55 General
Category: ONCOLOGY
02/24/2018 Novartis Pharmaceuticals Corporation MEKINIST (Drug), TAFINLAR Travel and Lodging Cash or cash equivalent $54.00 General
Category: ONCOLOGY
02/24/2018 Novartis Pharmaceuticals Corporation MEKINIST (Drug), TAFINLAR Travel and Lodging Cash or cash equivalent $44.18 General
Category: ONCOLOGY
02/24/2018 Novartis Pharmaceuticals Corporation MEKINIST (Drug), TAFINLAR Food and Beverage Cash or cash equivalent $31.42 General
Category: ONCOLOGY
02/23/2018 Novartis Pharmaceuticals Corporation TAFINLAR (Drug), MEKINIST Travel and Lodging In-kind items and services $218.00 General
Category: ONCOLOGY
12/06/2017 Amgen Inc. IMLYGIC (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,400.00 General
Category: Oncology
12/01/2017 Amgen Inc. Neulasta (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $800.00 General
Category: Oncology
11/15/2017 Amgen Inc. IMLYGIC (Biological) Travel and Lodging Cash or cash equivalent $3.96 General
Category: Oncology
11/01/2017 Amgen Inc. IMLYGIC (Biological) Food and Beverage In-kind items and services $95.47 General
Category: Oncology
09/15/2017 NOVADAQ TECHNOLOGIES INC. SPY Technology (Device), PINPOINT, LUNA Travel and Lodging Cash or cash equivalent $812.95 General
Category: Imaging Systems

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 13 426 508 $236,542 $48,714
2022 13 463 542 $273,246 $56,835
2021 13 479 556 $263,787 $59,448
2020 10 369 414 $143,394 $32,149
Total Patients
1,737
Total Services
2,020
Medicare Billing
$197,147
Procedure Codes
49

All Medicare Procedures & Services

49 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 64 92 $25,932 $6,727 25.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 111 137 $26,257 $6,576 25.0%
38525 Biopsy or removal of deep lymph nodes of underarm Facility 2023 19 19 $27,174 $6,031 22.2%
38510 Biopsy or removal of deep lymph nodes of neck Facility 2023 15 15 $26,142 $5,031 19.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 29 40 $16,584 $4,575 27.6%
38900 Imaging of lymph nodes during surgery Facility 2023 41 41 $17,427 $4,367 25.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 41 41 $15,677 $4,205 26.8%
11606 Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm Facility 2023 19 21 $27,621 $2,763 10.0%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 18 18 $9,464 $2,524 26.7%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 28 37 $8,275 $1,947 23.5%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2023 18 24 $7,741 $1,627 21.0%
13121 Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm Facility 2023 12 12 $15,300 $1,241 8.1%
13101 Complicated repair of wound of trunk, 2.6-7.5 cm Facility 2023 11 11 $12,949 $1,100 8.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 70 105 $27,377 $7,760 28.3%
38525 Biopsy or removal of deep lymph nodes of underarm Facility 2022 21 21 $31,435 $7,573 24.1%
38510 Biopsy or removal of deep lymph nodes of neck Facility 2022 23 23 $40,376 $7,549 18.7%
38900 Imaging of lymph nodes during surgery Facility 2022 52 52 $22,059 $5,618 25.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 94 113 $19,961 $5,109 25.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 50 50 $17,872 $4,810 26.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 26 38 $14,331 $4,435 30.9%
11606 Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm Facility 2022 26 29 $36,420 $4,052 11.1%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 25 25 $12,273 $3,589 29.2%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2022 30 36 $8,652 $1,827 21.1%
13121 Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm Facility 2022 16 16 $19,326 $1,658 8.6%
13101 Complicated repair of wound of trunk, 2.6-7.5 cm Facility 2022 15 15 $16,771 $1,610 9.6%

About Dr. John Vetto, MD

Dr. John Vetto, MD is a Surgery healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629086103.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Vetto, MD has received a total of $37,355 in payments from pharmaceutical and medical device companies, with $178.60 received in 2022. These payments were reported across 43 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($20,720).

As a Medicare-enrolled provider, Vetto has provided services to 1,737 Medicare beneficiaries, totaling 2,020 services with total Medicare billing of $197,147. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.

Practice Information

  • Specialty Surgery
  • Other Specialties Surgical Oncology
  • Location Portland, OR
  • Active Since 08/03/2006
  • Last Updated 03/12/2014
  • Taxonomy Code 208600000X
  • Entity Type Individual
  • NPI Number 1629086103

Products in Payments

  • Lymphoseek (Drug) $11,131
  • IMLYGIC (Biological) $9,709
  • MEKINIST (Drug) $7,270
  • TAFINLAR (Drug) $5,040
  • SPY Technology (Device) $2,055
  • Neulasta (Biological) $1,600
  • OPDIVO (Biological) $108.88
  • LIBTAYO (Biological) $69.72
  • SEG101 (Biological) $56.00
  • Perjeta (Biological) $52.17

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Surgery Doctors in Portland